Since founded by Dr. Kim Jin-Soo in 1999, ToolGen has mainly provided genome-editing products and services for research purposes. The company continued with its strenuous efforts and successfully developed therapeutic gene editing technologies of ZFN and TALEN as well as CRISPR in 2012, solidly establishing its prowess in the business field.
Leveraging on its original patent of CRISPR gene editing, ToolGen is currently funneling its research and development resources into the commercialization of patents and the development of gene-editing based therapeutics and plant and animal products.

ToolGen’s Vision

Innovate Genome
For better health,
happier life.

A healthy life without diseases
A wealthy life with evolved plants and animals

ToolGen’s Logo